The antigenic relationships among the original canine parvovirus type 2 (CPV-2) and the variants CPV-2a, - 2b, and - 2c were evaluated. Cross-antigenic evaluation revealed clear differences among the CPV variants, which were more appreciable by serum neutralization (SN) than by hemagglutination inhibition. Antigenic differences were found mostly between the original CPV-2 and the variants, but they were also observed among the variants CPV-2a, - 2b, and - 2c. The variant CPV-2c exhibited a unique antigenic pattern, since it was poorly recognized by the sera of animals immunized with CPV-2, CPV-2a, and CPV-2b. However, animals immunized with CPV-2c exhibited higher SN titers to CPV-2b than to the homologous virus CPV-2c. The observed antigenic differences might drive selection of CPV strains by generating differential immune pressure in the canine population, which raises concerns about vaccine efficacy.
Evaluation of the antigenic relationship among the canine parvovirus (CPV-2) variants
CAVALLI, Alessandra;MARTELLA, Vito;DESARIO, COSTANTINA;CAMERO, Michele;BELLACICCO, ANNA LUCIA;DE PALO, Pasquale;DECARO, Nicola;ELIA, Gabriella;BUONAVOGLIA, Canio
2008-01-01
Abstract
The antigenic relationships among the original canine parvovirus type 2 (CPV-2) and the variants CPV-2a, - 2b, and - 2c were evaluated. Cross-antigenic evaluation revealed clear differences among the CPV variants, which were more appreciable by serum neutralization (SN) than by hemagglutination inhibition. Antigenic differences were found mostly between the original CPV-2 and the variants, but they were also observed among the variants CPV-2a, - 2b, and - 2c. The variant CPV-2c exhibited a unique antigenic pattern, since it was poorly recognized by the sera of animals immunized with CPV-2, CPV-2a, and CPV-2b. However, animals immunized with CPV-2c exhibited higher SN titers to CPV-2b than to the homologous virus CPV-2c. The observed antigenic differences might drive selection of CPV strains by generating differential immune pressure in the canine population, which raises concerns about vaccine efficacy.I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.